PTC Therapeutics
PTCT
#2807
Rank
NZ$10.06 B
Marketcap
NZ$125.41
Share price
-1.18%
Change (1 day)
52.24%
Change (1 year)

PTC Therapeutics (PTCT) - Net assets

Net assets on the balance sheet as of September 2025 : -NZ$0.26 Billion

According to PTC Therapeutics 's latest financial reports the company has -NZ$0.26 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

PTC Therapeutics - Net assets on balance sheet (from 2012 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-NZ$1.95 Billion50.42%
2023-12-31$-NZ$1.3 Billion136.77%
2022-12-31$-NZ$0.55 Billion-26066.9%
2021-12-31$NZ$2.1 M-99.68%
2020-12-31$NZ$0.66 B-24.31%
2019-12-31$NZ$0.88 B68.78%
2018-12-31$NZ$0.52 B137.38%
2017-12-31$NZ$0.22 B27.59%
2016-12-31$NZ$0.17 B-47.72%
2015-12-31$NZ$0.33 B-13.32%
2014-12-31$NZ$0.38 B129.26%
2013-12-31$NZ$0.16 B-812.12%
2012-12-31$-NZ$23.34 Million-92.37%
2011-12-31$-NZ$0.31 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
NZ$74.30 B-28,831.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
NZ$28.75 B-11,219.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$1.03 B-501.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$2.19 B-947.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.38 B-250.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
NZ$3.13 B-1,311.02%๐Ÿ‡บ๐Ÿ‡ธ USA